- Research article
- Open Access
A multi-drug resistant Salmonella Typhimurium ST213 human-invasive strain (33676) containing the bla CMY-2 gene on an IncF plasmid is attenuated for virulence in BALB/c mice
© Wiesner et al. 2016
- Received: 16 October 2015
- Accepted: 30 January 2016
- Published: 9 February 2016
Classical strains of Salmonella enterica serovar Typhimurium (Typhimurium) predominantly cause a self-limiting diarrheal illness in humans and a systemic disease in mice. In this study, we report the characterization of a strain isolated from a blood-culture taken from a 15-year old woman suffering from invasive severe salmonellosis, refractory to conventional therapy with extended-spectrum cephalosporin (ESC).
The strain, named 33676, was characterized as multidrug-resistant Salmonella serogroup A by biochemical, antimicrobial and serological tests. Multilocus sequence typing (MLST) and XbaI macrorestrictions (PFGE) showed that strain 33676 belonged to the Typhimurium ST213 genotype, previously described for other Mexican Typhimurium strains. PCR analyses revealed the presence of IncA/C, IncFIIA and ColE1-like plasmids and the absence of the Salmonella virulence plasmid (pSTV). Conjugation assays showed that the ESC-resistance gene bla CMY-2 was carried on the conjugative IncF plasmid, instead of the IncA/C plasmid, as found in previously studied ST213 strains. Although the IncA/C plasmid conferred most of the observed antimicrobial resistances it was not self-conjugative; it was rather able to conjugate by co-integrating with the IncF plasmid. Strain 33676 was fully attenuated for virulence in BALB/c mice infections. Both type-three secretion system (T3SS), encoded in Salmonella pathogenicity islands 1 and 2 (SPI-1 and SPI-2), were functional in the 33676 strain and, interestingly, this strain produced the H2 FljB flagellin instead of the H1 FliC flagellin commonly expressed by S. enterica strains.
Strain 33676 showed two main features that differentiate it from the originally described ST213 strains: 1) the bla CMY-2 gene was not carried on the IncA/C plasmid, but on a conjugative IncF plasmid, which may open a new route of dissemination for this ESC-resistance gene, and 2) it expresses the H2 FljB flagella, in contrast with the other ST213 and most Typhimurium reference strains. To our knowledge this is the first report of an IncF bla CMY-2-carrying plasmid in Salmonella.
- Bacterial pathogenesis
- Antimicrobial resistance
- Multilocus sequence typing MLST
- Salmonella virulence plasmid pSTV
- Bacterial conjugation
- IncA/C plasmid
- IncF plasmid
- ColE1-like plasmid
- Plasmid co-integration
- Salmonella pathogenicity islands SPIs
Salmonella enterica are Gram-negative flagellated bacteria that cause salmonellosis, a food-borne disease in humans causing gastroenteritis and bacteremia worldwide. The most prevalent Salmonella serovars isolated from humans and other animals are Typhimurium and Enteritidis [1, 2]. Typhimurium strains cause gastroenteritis in humans and several animals, whereas in mice they produce a systemic infection similar to the enteric fever generated by the human-restricted serovar Typhi [3, 4]. In most S. enterica serovars, the antigenic formula is composed by two flagellar phases (H1 and H2). That is, Salmonella can express two different flagellin subunits, FliC and FljB, from two divergently oriented genes. The expression of FliC and FljB is controlled by phase variation, which involves the inversion of a 1 kb DNA containing the promoter of fljB, to express either fljB or fliC genes . Commonly, the S. enterica strains express the flagellar H1 phase. Although the role of flagella in motility, chemotaxis and pathogenesis is recognized, the biological significance of phase variation in Salmonella has been scarcely addressed [3, 6].
The majority of Salmonella virulence genes are clustered in regions distributed over the chromosome called Salmonella pathogenicity islands (SPIs), whereas others are found on the Salmonella virulence plasmid (pSTV) [7–10]. More than twenty SPIs have been described for Salmonella ; however, the well-studied are SPI-1 and SPI-2. Both SPI-1 and SPI-2 contain around 40 genes that encode a type-three secretion system (T3SS), which mediate the translocation of effector proteins into the eukaryotic host cells. The T3SS and effector proteins encoded in SPI-1 are necessary for Salmonella invasion of intestinal epithelial cells, and thus for the intestinal colonization leading to enteritis; whereas the T3SS and effector proteins encoded in SPI-2 are mainly required for Salmonella survival and replication inside macrophages, and hence for the systemic disease [3, 8]. The pSTV plasmid belongs to the F incompatibility group (IncF), harboring the spv operon, which is necessary to confer full virulence in mice [12–14]; however, the role of this plasmid in human infections is less clear. It has been accepted that pSTV is not required to cause gastroenteritis, but its association with human bacteremia is still in debate [12, 15, 16].
Antimicrobial resistance among Salmonella has been increasing, particularly in serovar Typhimurium . Antimicrobial therapy is not required for most Salmonella infections, but it may be lifesaving in patients with or at risk for extra-intestinal infection . Several studies have addressed the increased risk for hospitalization, invasive illness, and death posed by multi-drug resistant (MDR) Salmonella [18–20].
In Mexico, the results of an integrated food chain surveillance program showed that Typhimurium was the serovar most frequently associated with human infections, and particularly high MDR levels were recorded in both humans and food-animals . Zaidi et al. reported the emergence of MDR Typhimurium strains with extended-spectrum cephalosporin (ESC) resistance in Yucatán, as the cause of severe enteric and systemic infections in children . The ESC-resistance was found to be determined by the bla CMY-2 gene, which confers resistance to ceftriaxone (CRO), the antibiotic of choice for treating severe gastroenteritis and systemic infections. In a previous study, we analyzed a sample of 114 Typhimurium strains from the surveillance program in Mexico by multi-locus sequence typing (MLST), macro-restrictions (PFGE), and PCR typing for accessory genes involved in virulence and anti-microbial resistance . We found that all the MDR strains with the ESC-resistant phenotype carried the bla CMY-2gene on a large plasmid (150 kb) of the IncA/C incompatibility group (IncA/C), and that these strains belonged to a new chromosomal multi-locus genotype, designated in the MLST database as sequence type 213 (ST213) [23, 24]. Another distinctive feature of the ST213 genotype was the lack of the pSTV, which contains virulence determinants and is characteristic of serovar Typhimurium, which was nevertheless present in strains with other genotypes in the Mexican population, such as ST19, ST302 and ST429 .
In this work we studied a Salmonella strain, named 33676, isolated from a blood-culture taken from a 15-year old young woman suffering a febrile illness with invasive severe pancolitis, refractory to conventional therapy with ESC. The aim of the study was to characterize genetic and phenotypic attributes of strain 33676, to get insights on the biology behind the unusual severe clinical manifestations observed in a patient with no signs of malnutrition, immunodeficiency or other underlying medical conditions. A battery of molecular and phenotypic approaches were applied to analyze strain 33676, including MLST, PFGE, PCR detection of plasmid markers, along with antimicrobial susceptibility tests, protein secretion profiles, and assays for virulence in the murine host. The usefulness of these molecular and phenotypic typing methods in the detection and classification of Salmonella strains, and in the context of host adaptation and the current epidemiological situation is discussed.
Since this is a retrospective case-report of a patient cared during routine clinical practice on May 2011, no written or informed consent was obtained. Laboratory studies were part of the routine diagnostic work-out in a patient with diarrhea and a fever. There was no submission to an institutional review board (ethics committee) at the hospital, as this report did not imply the implementation and conductance of a designed research protocol with human participants. Blood and stool samples were collected by laboratory technicians of the hospital, as part of the routine clinical care of the patient. The unit of study in the present communication was a bacterial strain, isolated from this patient, which was characterized in a research laboratory. Microbiologists carrying out this task coded this bacterial strain omitting any disclosure of the patient’s identity.
The studies performed with animals were carried out in strict accordance with the recommendations in the guide for the Care and Use of Laboratory Animals of the National Institutes of Health, USA. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Instituto de Biotecnología de la UNAM, Mexico (Permit Number: 286). Animals were sacrificed before signs of suffering appeared.
Strain isolation, antimicrobial susceptibility tests, and serological classification
The bacterial strain described in this report was isolated from a previously healthy 15-year old young woman who attended the emergency room of a private hospital in Mexico City, with a 4-day duration clinical picture characterized by fever, vomiting, severe abdominal pain and watery bloody diarrhea. The patient was started with amoxicillin/clavulanic acid medication 72 h before hospital admission. Upon clinical examination, one gram of intravenous ceftriaxone every 12 h was commenced. At day 4, due to the adverse clinical course of the disease, and based on the report of the antibiotic susceptibility tests for the bacterium (Salmonella) isolated from stool and blood cultures (see below), ceftriaxone was changed to ertapenem. Clinical improvement 24 h after this therapeutic modification was observed. At day 9, the patient was discharged from the hospital with complete remission of all systemic and abdominal signs and symptoms.
The microbiological investigation of stool and blood samples was performed at the Instituto Nacional de Ciencias Médicas y de la Nutrición Salvador Zubirán, using the VITEK-2 AST-115 panel (bioMerieux), which allows microbial identification of bacteria and antibiotic susceptibility by the broth microdilution method according to Clinical and Laboratory Standards Institute .
Bacterial strains used in this study
Typhimurium human invasive ST213 strain
Typhimurium human invasive ST213 strain
Typhimurium ST19 reference strain
SL1344 derivative, ΔssrB::kan, strain MJW112
SL1344 derivative, ΔSPI-1::kan
SL1344 derivative, ΔSPI-2::kan
E. coli laboratory strain
DNA extraction, MLST and PFGE
Genomic DNA was extracted using standard laboratory protocols . PCR amplifications were performed using Taq DNA polymerase (Invitrogen, Brazil), and the products were purified with a purification kit from Qiagen (Valencia, California, USA), and submitted for sequencing at Macrogen (Seoul, South Korea).
The seven loci used in the S. enterica MLST scheme were aroC, dnaN, hemD, hisD, purE, sucA and thrA . The PCR primers and conditions used were those reported in the MLST web site (http://mlst.warwick.ac.uk/mlst/dbs/Senterica). The sequences at each locus were submitted to the web database for allele assignment, and the combination of alleles was assigned to a sequence type (ST).
The restriction of genomic DNA with XbaI was resolved by pulsed-field gel electrophoresis (PFGE) using the standardized protocol from PulsNet CDC . The XbaI restriction patterns were clustered using the unweighted pair-group method with arithmetic averages. The analysis was performed with GelComparII using band matching and Dice coefficients with a 1.5 % band position tolerance.
PCR detection of plasmids, virulence and antimicrobial-resistance genes
We determined by PCR the presence of plasmids of the incompatibility groups IncA/C, ColE1-like, IncFIIA, IncHI2, IncI1 and IncX, which are among the most frequently reported to carry antimicrobial resistance in enteric bacteria . Three regions previously used as markers for the IncA/C plasmids were amplified: bla CMY-2, conferring resistance to ESC; floR, conferring resistance to chloramphenicol; and the 2 kb class 1 integron (dfrA12, orfF and aadA2), conferring resistance to trimethoprim and streptomycin [23, 24]. Three regions distributed along the pSTV were detected as well by PCR: rck, spvC and traT, involved in resistance to serum and survival in macrophages [12, 13, 30]. To detect the presence of the genes encoding flagellar subunits FliC and FljB, PCR amplification were performed for fliC and fljB genes. The PCR conditions were those previously reported [23, 24], and the primers used are listed in Additional file 1: Table S1. Primers used in this study.
Conjugation and transformation experiments
To determine the transfer capabilities of the plasmid carrying the bla CMY-2 gene, conjugation experiments were performed as previously reported [24, 31]. A spontaneous rifampicin-resistant mutant of the nalidixic acid-resistant Escherichia coli DH5α strain was used as recipient (Table 1), and transconjugants were selected on rifampicin (100 μg/ml), nalidixic acid (60 μg/ml) and ceftriaxone (CRO) (2 μg/ml). Transfer frequencies were calculated as the number of transconjugants per donor. The conjugation experiments were repeated three times.
To obtain transformants with the different plasmids of strain 33676, the alkaline lysis plasmid extraction was used as donor DNA to electroporate competent DH5α strains. Ceftriaxone (2 μg/ml), tetracycline (12 μg/ml) and chloramphenicol (60 μg/ml), separately, were used for selection of transformants. Transformant colonies were analyzed by PCR with primers for the IncFIIA and IncA/C incompatibility groups (Additional file 1: Table S1. Primers used in this study) as described above.
Competitive index (CI) assays for mice virulence
Mice infections and calculation of the competitive index (CI) were performed as described previously [32, 33]. Briefly, five BALB/c mice were infected orally with an equal mix of 104 bacteria of SL1344 standard reference strain and test strains. The test strains were the two Mexican Typhimurium strains isolated from human invasive infections, 33676 or YU39, and the ΔssrB::kan SL1344 derivative strain lacking the SsrB regulator necessary for the expression of SPI-2 genes (Table 1). After three days of infection, animals were sacrificed by CO2 asphyxiation followed by cervical dislocation, and the bacterial load in the spleen and liver was quantified from organ homogenates by plating serial 10-fold dilutions of cell lysates on LB agar plates and counting the colony-forming units (CFUs) for each strain. Ampicillin resistance of 33676 and YU39, as well as kanamycin resistance of ΔssrB, were used to differentiate these strains from SL1344, which is not resistant to these antibiotics. The CI was calculated as the ratio 33676/SL1344, YU39/SL1344 or ΔssrB/SL1344 of CFUs obtained from the mouse organs, divided by their respective ratio from the initial inoculum .
Protein secretion analysis and flagella characterization
Analysis of the proteins secreted by the type III secretion systems encoded in SPI-1 and SPI-2 was performed as described previously . Secretion mediated by SPI-1 and SPI-2 was determined in bacterial cultures grown for 9 h in LB and for 16 h in N-minimal medium (N-MM) at pH 5.8, respectively. Proteins contained in 1.5 ml samples of culture supernatants were precipitated by the addition of 10 % (v/v) trichloroacetic acid and overnight incubation at 4 °C. Precipitated proteins were concentrated by centrifugation at 16,000 g for 30 min at 4 °C. Pellets were resuspended in SDS-PAGE loading buffer containing 10 % saturated Tris base. Samples were subjected to SDS-PAGE analysis, using 12 % polyacrylamide gels. The SPI-1-encoded proteins SipA, SipB, SipC and SipD, as well as the flagellar protein FliC or FljB, were detected by staining with Coomassie Brilliant Blue R-250. The SPI-2-encoded SseB protein was detected by Western blot with an anti-SseB polyclonal antibody, as described previously . The intense band of about 57 kDa secreted by strain 33676 was excised from the gel, digested with trypsin, and analyzed by liquid chromatography-mass spectrometry at the Unidad de Proteómica of the Instituto de Biotecnología, UNAM.
Strain 33676 was identified as an MDR Salmonella serogroup A 1, 4, 5 (+)
We studied a strain isolated from a patient with severe pancolitis and bacteremia. Bacterial isolates were obtained both from stool and blood samples. The biochemical tests showed that the isolates belonged to Salmonella. Serological classification showed that the isolates were from the Salmonella serogroup A, factor 1, 4, 5 (+). The isolates were resistant by minimum inhibitory concentrations (MICs) break-points to 12 out of 19 antimicrobials: ampicillin (MIC > =32), amoxicillin/clavulanic acid (MIC > =32), ticarcillin/clavulanic acid (MIC > =128), piperacillin/tazobactam (MIC > =128), cefazolin (MIC > =64), ceftazidime (MIC > =64), ceftriaxone (MIC > =64), amikacin (MIC < =2), gentamicin (MIC > =16), ciprofloxacin (MIC =2), nitrofurantoin (MIC = 128) and trimethoprim/sulfamethoxazole (MIC > =320). Sensitivity was recorded to cefepime, ertapenem, imipenem, meropenem, norfloxacin, tigecycline and fosfomycine. Resistance to chloramphenicol (30 μg/ml), streptomycin (100 μg/ml) and tetracycline (12 μg/ml) was also recorded by growth in LB broth supplemented with these antibiotics, which were later used to analyze the conjugation ability of the strain (see below).
For further studies, the strain isolated from the blood-culture was named as 33676. The antimicrobial susceptibility tests showed that strain 33676 was MDR, which explains the empiric therapeutic failure obtained when the patient was treated with amoxicillin/clavulanic acid or ceftriaxone, whereas positive response was obtained with ertapenem, and the patients’ health was restored.
MLST and PFGE showed that strain 33676 belongs to Typhimurium ST213
The combination of alleles for the seven loci used in the S. enterica MLST scheme showed that strain 33676 belongs to ST213, which was initially reported for Mexican Typhimuirum strains , and has been recently reported for other Typhimurium strains from the United Kingdom and Netherlands (http://mlst.warwick.ac.uk/mlst/dbs/Senterica). Achtman et al. had provided evidence that MLST can be used to assign strains to Salmonella serovars, since the housekeeping genes used in the MLST scheme are conserved among salmonellae and hence reflect the evolutionary history of the strains . To set strain 33676 in the context of our previously analyzed Typhimurium ST213 strains, sub-typing was performed by restriction of genomic DNA with XbaI resolved by pulsed-field gel electrophoresis (PFGE). The comparison of the XbaI restriction profile with those of the Mexican Typhimurium strains reported by Wiesner et al.  showed that strain 33676 grouped within the ST213 cluster (Additional file 2: Figure S1. Strain 33676 belongs to the Mexican ST213 population). Under the evidence provided by the MLST and PFGE data, strain 33676 belongs to the Typhimurium ST213 evolutionary lineage.
Strain 33676 carries IncA/C, IncF and ColE-1-like plasmids
The blaCMY-2 gene is borne on a conjugative IncF plasmid
The mobility of the 33676 bla CMY-2 gene was studied by conjugation assays selecting DH5α transconjugants resistant to ceftriaxone. DH5α transconjugants resistant to CRO were found at a frequency of 5.9-1.9 x 10−6. The transconjugants were evaluated by PCR for the presence of the repA/C, bla CMY-2 and floR markers of the IncA/C plasmid. Unexpectedly, the transconjugants were positive only for bla CMY-2, but not for repA/C and floR markers, indicating that bla CMY-2 was not carried on the IncA/C plasmid. Positive amplification was recorded with the IncFIIA primers, indicating that in strain 33676 the bla CMY-2 gene was located on a conjugative IncF plasmid. The plasmid profile displayed by the transconjugants revealed that the 120 kb plasmid was the IncF plasmid carrying the bla CMY-2 gene (Fig. 1, lane 6).
The MDR IncA/C plasmid is not conjugative but can co-integrate with the conjugative IncF plasmid
A transformation assay was performed, using the alkaline-lysis plasmid extract of 33676 as donor DNA, and DH5α strain as recipient. Selection was performed with ceftriaxone to obtain the IncF plasmid with the bla CMY-2 gene, and with chloramphenicol or tetracycline to select for the IncA/C plasmid. The plasmid profiles and the PCR typing with the IncFIIA and IncA/C primers, confirmed that the transformant colonies obtained with ceftriaxone only carried the IncF plasmid (Fig. 1, lane 3), while the colonies obtained with chloramphenicol or tetracycline only contained the IncA/C plasmid (Fig. 1, lanes 2 and 4).
The amplification products of the bla CMY-2 gene present in the IncF plasmid transformants, and the 2 kb integron (conferring resistance to streptomycin and trimethoprim/sulfamethoxazole) present in the IncA/C plasmid transformants, were sequenced and showed nucleotide sequences identical to those reported for the other Mexican ST213 strains . Antimicrobial susceptibility tests for the transformant colonies showed that the IncF plasmid accounted for resistance to penicillin and cephalosporin antibiotics, whereas the IncA/C plasmid provided resistance to the other antibiotic classes (chloramphenicol, gentamicin, streptomycin, tetracycline and trimethoprim/sulfamethoxazole). These results indicated that most of the resistance determinants were carried by the MDR IncA/C plasmid, while the IncF plasmid carried only the bla CMY-2 gene which accounts for penicillin and cephalosporin resistances.
To determine if the IncA/C plasmid was conjugative, a conjugation experiment was performed selecting with tetracycline, using strain 33676 as the donor and DH5α as the recipient strain. Transconjugant colonies were obtained at a frequency of 1 x 10−5. Transconjugants were positive for the amplification with the IncA/C primers; however, they were also positive for amplification with the IncF primers, indicating that both plasmids were transferred. The plasmid profiles of the tetracycline-resistant transconjugants displayed only one plasmid, larger than the IncA/C plasmid (Fig. 1, lane 5). PCR amplifications with the bla CMY-2, floR and integron regions were positive, and the antimicrobial resistance profiles showed resistance to 10 out of the 15 resistances, as found for the parental 33676 strain, suggesting that the large plasmid was formed by the co-integration of the complete IncA/C and IncF plasmids.
We hypothesized that the IncA/C plasmid of strain 33676 was not self-conjugative, and that co-integration with the IncF plasmid was necessary to be transferred. To test this hypothesis, a conjugation assay was performed, using as donor a DH5α transformant strain carrying the IncA/C plasmid, and DH5α as recipient. No transconjugants were obtained, supporting the notion that the IncA/C plasmid is not self-conjugative, as previously found for the other ST213 strains [24, 31].
Strains 33676 and YU39 are fully attenuated for virulence in BALB/c mice
Competitive indexes (CIs)a for mice infections between the reference strain SL1344, human invasive strains 33676 and YU39, and the SPI-2 mutant strain ΔssrB
<5 x 10−8
< 7 x 10−8
< 5 x 10−8
< 8 x 10−7
< 8 x 10−8
< 3 x 10−8
Strain 3376 has functional SPI-1- and SPI-2-encoded type III secretion systems and produces the flagellar subunit FljB
The results of MLST along with PFGE provided unequivocal evidence that this strain belonged to the ST213 genotype of serovar Typhimurium (Additional file 2: Figure S1. Strain 33676 belongs to the Mexican ST213 population). PCR typing, in combination with plasmid profiling, allowed to discover that in strain 33676 the ESC-resistance gene, bla CMY-2, was carried on an IncF plasmid. This is in contrast with the previously analyzed ST213 strains, which carried this gene on IncA/C plasmids, as found for other Typhimurium strains [24, 38]. Despite the fact that strain 33676 indeed harbors an IncA/C plasmid, which accounts for most of the MDR phenotype, the bla CMY-2 gene maps to a conjugative IncF plasmid. Although IncF plasmids have been involved in antibiotic resistance in enteric bacteria [39–41], there is only one report of an IncF plasmid carrying bla CMY-2 in E. coli ; however, to our knowledge this is the first report of an IncF bla CMY-2-carrying plasmid in Salmonella.
In a previous conjugation study, with another ST213 donor strain (YU39), we found that the bla CMY-2 gene was transferred to recipient strains by means of co-integration with a conjugative IncX1 plasmid, or by transposition of the bla CMY-2 region into the conjugative IncX1 plasmid . In the present study, when strain 33676 was challenged for conjugation using as selection an antibiotic carried by the IncA/C plasmid (tetracycline), chimeric plasmids containing the molecular markers and antibiotic resistance profile of both IncA/C and IncF plasmids were obtained. The co-integration of the MDR IncA/C plasmid with the conjugative IncF-bla CMY-2 carrying plasmids in strain 33676, resembles the co-integration found among the IncA/C-bla CMY-2 plasmid and the conjugative IncX1 plasmid previously recorded in strain YU39 . In both cases, the non-conjugative IncA/C plasmids took advantage of the conjugation machinery of a co-resident plasmid to transfer their antimicrobial resistance capabilities. In fact, it is possible to observe a faint band of the size of the co-integrate formed by the IncF and IncA/C on the plasmid profile of strain 33676 (Fig. 1, lanes 1 and 7), but not in the IncA/C and IncF transformants or transconjugant strains, supporting the notion that the co-integrate plasmid is naturally formed at low frequencies in the wild-type strain, even under non-selective pressure conditions without antibiotic. Taken together, these phenomena highlight the plastic nature of the plasmid compartments of the genomes of these ST213 Typhimurium strains.
In contrast to the classical Typhimurium strains, such as SL1344, which cause gastroenteritis in humans and systemic infection in mice, the Typhimurium ST213 strains 33676 and YU39 were isolated from human systemic infections and both were fully attenuated for virulence in mice (Table 2). A common feature of the ST213 strains is the lack of pSTV . Many studies have demonstrated that pSTV is necessary for full virulence in the mouse [12, 13]. Evidence indicates that, in mice, the spv genes enable Typhimurium strains to infect the spleen and the liver by increasing the rate of bacterial replication within host cells. Plasmid-cured strains are able to colonize and persist in the spleen and the liver, but bacterial growth is controlled by host defenses and infection does not develop . This is in agreement with the findings of Kapperud et al. , which studied a large Typhimurium outbreak traced to contaminated chocolate, and found that the strains lacking the pSTV were not virulent to mice, but caused acute, hemorrhagic diarrhea in children less than two years old . Furthermore, we have tested other ST213 strains (lacking pSTV) and none of them were virulent in mice (data not shown). Therefore, the lack of pSTV likely explains the attenuated virulence of ST213 strains in mice. However, chromosomal-encoded factors are also required and can determinate differential virulence phenotype in mice of Typhimurium strains . García-Quintanilla et al. demonstrated that the transfer of the pSTV from mice-virulent strains (SL1344 and ATCC 14028) did not provide virulence in mice to the non-virulent strain LT2 cured from its pSTV . Furthermore, Heithoff et al.  suggested that Salmonella isolates derived from human salmonellosis patients are distinct from those of animal (chicken, cow, dog, horse, sheep and turkey) origin. They found that a fraction (19 %) of the Typhimurium strains (harboring the pSTV) derived from human salmonellosis patients were virulent in mice, in contrast with the virulent phenotype exhibited by all the animal isolates (harboring pSTV) examined .
Previously, since we found that in the Mexican Typhimurium population the pSTV was significantly associated with human isolates, and that ST213 strains lacking pSTV caused most of the systemic infection cases and were significantly associated with animal sources, we suggested that pSTV could be involved in human host adaptation . However, the involvement of pSTV in human systemic infections is still controversial and deserves more research [12, 15, 16, 47]. Together, these studies indicate that bacterial-host interactions are complex, and several genetic elements are involved in the outcome of infection, and, that virulence in mice cannot be directly extrapolated to human virulence and vice versa [3, 30, 43, 47].
In addition to the defect in virulence showed by ST213 strains in mice, our preliminary results support the notion that strains 33676 and YU39 have a diminished ability to invade, but not to replicate within HeLa cells (data not shown). The absence of pSTV could be related to the invasion defect showed by 33676 and YU39 strains, since it has been demonstrated that pSTV is also necessary for cell invasion [4, 12, 48, 49].
The mechanisms employed by the pSTV-devoid ST213 strains to cause systemic disease in humans open new avenues for the study of Salmonella-host interactions. In the present study, it was demonstrated that the T3SSs from SPI-1 and SPI-2, which are essential for Salmonella virulence, are functional in strain 33676 (Fig. 2). Furthermore, it was found that strain 33676 expresses FljB flagellar subunit (Fig. 2a), which is unusual in Typhimurium; most of the reference strains, such as SL1344 (Fig. 2a), LT2 and 14028S express FliC flagella [6, 37]. Flagella-based motility is required for the initial contact of Typhimurium with epithelial cells . Even when strain 33676 expresses the FljB flagellar subunit, instead of FliC expressed by strains SL1344 and YU39, the motility of these three strains was similar on LB plates containing soft agar (data not shown), which supports that a difference in motility is not involved in the invasion defect showed by strains 33676 and YU39. In a previous study, the effect of FljB and FliC on mice virulence was determined, by constructing phase-locked derivative strains . The authors found that a Typhimurium classical strain locked-ON (expressing only FljB) was attenuated for virulence in the mouse, and the authors concluded that the ability to switch to the FliC phase has a selective advantage for Typhimurium to survive in mice . However, in this study we found that, although the 33676 and YU39 strains express FljB and FliC (Fig. 2a and Additional file 3: Figure S2), respectively, they show similar virulence phenotypes (Table 2). Therefore, the expression of FljB, instead FliC, probably does not determine the virulence attenuation of the 33676 strain in mice, but it could be relevant for infection to humans. It has been established that a decreased production of FliC flagella reduces the inflammatory response , but the effect of FljB flagella on the human immune response remains to be studied.
ST213 was reported to be an emergent genotype in Mexico, characterized by the lack of pSTV, and the presence of multiple-drug resistance determinants, most of which are carried by IncA/C plasmids [23, 24]. We alerted about the emergence of the MDR genotype ST213 in Mexico, carrying resistance to ESC, which caused six out of the seven human systemic infections cases included in the study [22, 23]. The finding that strain 33676 (isolated in 2011) belongs to the MDR ST213 lineage indicates that this genotype continues to be a leading cause of disease in Mexico.
Strain 33676 shared most of the features studied in the ST213 surveillance population. However, two distinct features distinguished the originally described ST213 strains from strain 33676. First, the bla CMY-2 gene was not carried on the IncA/C plasmid, but on a conjugative IncF plasmid. And second, strain 33676 expresses the H2 FljB flagella. The antimicrobial resistance profile of strain 33676 increased, since ciprofloxacin resistance was not recorded in the 2000-2005 isolates . These findings indicate that the emergent ST213 genotype is spreading and diversifying in Mexico.
Strain 33676 caused invasive disease in a young woman with no signs of malnutrition, immunodeficiency or other underlying medical conditions, which is unusual; since Salmonella systemic infections are more likely to occur in young children, immunologically compromised patients, and patients with comorbid medical conditions, such as malnutrition [3, 17, 52]. Invasive MDR Typhimurium strains have emerged as prominent cause of bloodstream infections worldwide in the last three decades [18–20, 23, 53–56]. Recently, the Typhimurium genotype ST313 has emerged as a new pathogen in sub-Saharan Africa, [51, 52]. ST313 is an MDR genotype characterized by harboring a version of pSTV carrying antibiotic resistance genes, and by signs of chromosomal degradation, with a higher number of pseudogenes as compared with other Typhimurium strains . The ST313 genome degradation could account for adaptation to cause invasive disease in human beings, and also human-to-human transmission . These two features are similar to those of the human-restricted serovar Typhi. In this respect, preliminary analysis of the complete genome of strain 33676  showed a four-fold higher number of pseudogenes than those found in the YU39 genome . Further functional analyses are necessary to address the impact of the pseudogenes on the pathogenesis of strain 33676.
We agree with Davies and Davies , in that antibiotic resistance can be considered as a marker concurrent with virulence factors; as some MDR strains have also acquired increased virulence and enhanced transmissibility . Since many studies have addressed the importance of the animal reservoirs in the spread of MDR Salmonella throughout the food chain [2, 21, 60, 61], it is necessary to make efforts to restart the epidemiological surveillance program in Mexico to address the prevalence of ST213 strains, and the emergence of new variants, in the human population and the animal-production settings.
In this study, a bacterial isolate that caused severe gastrointestinal and systemic (bacteremia) infections in a healthy young woman was characterized using a battery of molecular tools. Two main features distinguished strain 33676 from the originally described ST213 strains. First, the bla CMY-2 gene was not carried on the IncA/C plasmid, but on a conjugative IncF plasmid, which may open a new route of dissemination for this ESC-resistance gene. Second, strain 33676 expresses the H2 FljB flagella, in contrast with the other ST213 and most Typhimurium reference strains. The expression of FljB, instead FliC, probably does not determine the virulence attenuation of the 33676 strain in mice, but it could be relevant for infection to humans.
To our knowledge this is the first report of an IncF bla CMY-2-carrying plasmid in Salmonella. Moreover, the co-integration of the MDR IncA/C plasmid with the conjugative IncF-bla CMY-2 carrying plasmid highlights the plastic nature of the plasmid compartment of this Typhimurium strain.
This study was supported by grants from CONACyT (179946 to EC and 179071 to VHB) and DGAPA/UNAM (IN201513 to EC and IN205512 to VHB). Also partial financial support was obtained from CONACyT grant 154287 to José Luis Puente. We are grateful to Pablo Vinuesa for critical reading of the manuscript; to Areli Martínez-Gamboa and Ernesto Maravilla for the characterization of strain 33676 at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; to Jeannette Barba León for typing of 33676 strain by PFGE at the Universidad de Guadalajara; to Francisco Javier Santana Estrada and Lucía Perezgasga Ciscomani for technical support; and to Eugenio López, Santiago Becerra, Paul Gaytán y Jorge Yáñez from the Unidad de Síntesis y Secuenciación of the Instituto de Biotecnología, UNAM.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hendriksen RS, Vieira AR, Karlsmose S, Lo Fo Wong DM, Jensen AB, Wegener HC, et al. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: results of quality assured laboratories from 2001 to 2007. Foodborne Pathog Dis. 2011;8(8):887–900. doi:10.1089/fpd.2010.0787.View ArticlePubMedGoogle Scholar
- Hoelzer K, Moreno Switt AI, Wiedmann M. Animal contact as a source of human non-typhoidal salmonellosis. Vet Res. 2011;42(1):34. doi:10.1186/1297-9716-42-34.PubMed CentralView ArticlePubMedGoogle Scholar
- Fabrega A, Vila J. Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation. Clin Microbiol Rev. 2013;26(2):308–41. doi:10.1128/CMR.00066-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Haraga A, Ohlson MB, Miller SI. Salmonellae interplay with host cells. Nat Rev Microbiol. 2008;6(1):53–66. doi:10.1038/nrmicro1788.View ArticlePubMedGoogle Scholar
- Zieg J, Silverman M, Hilmen M, Simon M. Recombinational switch for gene expression. Science. 1977;196(4286):170–2.View ArticlePubMedGoogle Scholar
- Ikeda JS, Schmitt CK, Darnell SC, Watson PR, Bispham J, Wallis TS, et al. Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesis. Infect Immun. 2001;69(5):3021–30. doi:10.1128/IAI.69.5.3021-3030.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Groisman EA, Ochman H. How Salmonella became a pathogen. Trends Microbiol. 1997;5(9):343–9.View ArticlePubMedGoogle Scholar
- Hensel M. Evolution of pathogenicity islands of Salmonella enterica. Int J Med Microbiol. 2004;294(2-3):95–102.View ArticlePubMedGoogle Scholar
- Porwollik S, McClelland M. Lateral gene transfer in Salmonella. Microbes Infect. 2003;5(11):977–89.View ArticlePubMedGoogle Scholar
- Silva C, Wiesner M, Calva E. The Importance of Mobile Genetic Elements in the Evolution of Salmonella: Pathogenesis, Antibiotic Resistance and Host Adaptation. In: Kumar Y, editor. Salmonella - A Diversified Superbug. Rijeka, Croatia: InTech; 2012. p. 231–54.Google Scholar
- Sabbagh SC, Forest CG, Lepage C, Leclerc JM, Daigle F. So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium and Typhi. FEMS Microbiol Lett. 2010;305(1):1–13. doi:10.1111/j.1574-6968.2010.01904.x.View ArticlePubMedGoogle Scholar
- Guiney DG, Fierer J. The Role of the spv Genes in Salmonella Pathogenesis. Front Microbiol. 2011;2:129. doi:10.3389/fmicb.2011.00129.PubMed CentralView ArticlePubMedGoogle Scholar
- Rotger R, Casadesus J. The virulence plasmids of Salmonella. Int Microbiol. 1999;2(3):177–84.Google Scholar
- Gulig PA, Doyle TJ. The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice. Infect Immun. 1993;61(2):504–11.PubMed CentralPubMedGoogle Scholar
- Chiu CH, Chu C, Ou JT. Lack of evidence of an association between the carriage of virulence plasmid and the bacteremia of Salmonella typhimurium in humans. Microbiol Immunol. 2000;44(9):741–8.View ArticlePubMedGoogle Scholar
- Fierer J, Krause M, Tauxe R, Guiney D. Salmonella typhimurium bacteremia: association with the virulence plasmid. J Infect Dis. 1992;166(3):639–42.View ArticlePubMedGoogle Scholar
- Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32(3):331–51. doi:10.1086/318514.View ArticlePubMedGoogle Scholar
- Martin LJ, Fyfe M, Dore K, Buxton JA, Pollari F, Henry B, et al. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections. J Infect Dis. 2004;189(3):377–84. doi:10.1086/381270.View ArticlePubMedGoogle Scholar
- Varma JK, Greene KD, Ovitt J, Barrett TJ, Medalla F, Angulo FJ. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002. Emerg Infect Dis. 2005;11(6):943–6. doi:10.3201/eid1106.041231.PubMed CentralView ArticlePubMedGoogle Scholar
- Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis. 2005;191(4):554–61. doi:10.1086/427263.View ArticlePubMedGoogle Scholar
- Zaidi MB, Calva JJ, Estrada-Garcia MT, Leon V, Vazquez G, Figueroa G, et al. Integrated food chain surveillance system for Salmonella spp. in Mexico. Emerg Infect Dis. 2008;14(3):429–35.PubMed CentralView ArticlePubMedGoogle Scholar
- Zaidi MB, Leon V, Canche C, Perez C, Zhao S, Hubert SK, et al. Rapid and widespread dissemination of multidrug-resistant blaCMY-2 Salmonella Typhimurium in Mexico. J Antimicrob Chemother. 2007;60(2):398–401.View ArticlePubMedGoogle Scholar
- Wiesner M, Zaidi MB, Calva E, Fernandez-Mora M, Calva JJ, Silva C. Association of virulence plasmid and antibiotic resistance determinants with chromosomal multilocus genotypes in Mexican Salmonella enterica serovar Typhimurium strains. BMC Microbiol. 2009;9:131.PubMed CentralView ArticlePubMedGoogle Scholar
- Wiesner M, Calva E, Fernandez-Mora M, Cevallos MA, Campos F, Zaidi MB, et al. Salmonella Typhimurium ST213 is associated with two types of IncA/C plasmids carrying multiple resistance determinants. BMC Microbiol. 2011;11(1):9. doi:10.1186/1471-2180-11-9.PubMed CentralView ArticlePubMedGoogle Scholar
- NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Document M7-A6. Approved standard-Sixth edition. ed. NCCLS: Wayne, PA; 2002.Google Scholar
- Sambrook J, Russell DW. Molecular cloning. A laboratory manual. Third ed. New York: Cold Spring Harbor Laboratory Press; 2001.Google Scholar
- Kidgell C, Reichard U, Wain J, Linz B, Torpdahl M, Dougan G, et al. Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect Genet Evol. 2002;2(1):39–45.View ArticlePubMedGoogle Scholar
- Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis. 2001;7(3):382–9.PubMed CentralView ArticlePubMedGoogle Scholar
- Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63(3):219–28.View ArticlePubMedGoogle Scholar
- van Asten AJ, van Dijk JE. Distribution of “classic” virulence factors among Salmonella spp. FEMS Immunol Med Microbiol. 2005;44(3):251–9. doi:10.1016/j.femsim.2005.02.002.View ArticlePubMedGoogle Scholar
- Wiesner M, Fernandez-Mora M, Cevallos MA, Zavala-Alvarado C, Zaidi MB, Calva E, et al. Conjugative transfer of an IncA/C plasmid-borne blaCMY-2 gene through genetic re-arrangements with an IncX1 plasmid. BMC Microbiol. 2013;13:264. doi:10.1186/1471-2180-13-264.PubMed CentralView ArticlePubMedGoogle Scholar
- Rodríguez-Morales O, Fernández-Mora M, Hernández-Lucas I, Vázquez A, Puente JL, Calva E. Salmonella enterica serovar Typhimurium ompS1 and ompS2 mutants are attenuated for virulence in mice. Infect Immun. 2006;74(2):1398–402. doi:10.1128/IAI.74.2.1398-1402.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Segura I, Casadesús J, Ramos-Morales F. Use of mixed infections to study cell invasion and intracellular proliferation of Salmonella enterica in eukaryotic cell cultures. J Microbiol Methods. 2004;56(1):83–91.View ArticlePubMedGoogle Scholar
- Martínez LC, Yakhnin H, Camacho MI, Georgellis D, Babitzke P, Puente JL, et al. Integration of a complex regulatory cascade involving the SirA/BarA and Csr global regulatory systems that controls expression of the Salmonella SPI-1 and SPI-2 virulence regulons through HilD. Mol Microbiol. 2011;80(6):1637–56. doi:10.1111/j.1365-2958.2011.07674.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Achtman M, Wain J, Weill FX, Nair S, Zhou Z, Sangal V, et al. Multilocus sequence typing as a replacement for serotyping in Salmonella enterica. PLoS Pathog. 2012;8(6), e1002776. doi:10.1371/journal.ppat.1002776.PubMed CentralView ArticlePubMedGoogle Scholar
- Tsolis RM, Xavier MN, Santos RL, Baumler AJ. How to become a top model: impact of animal experimentation on human Salmonella disease research. Infect Immun. 2011;79(5):1806–14. doi:10.1128/IAI.01369-10.PubMed CentralView ArticlePubMedGoogle Scholar
- Macnab RM. Flagella and motility. In: Neidhardt FC, Curtiss III R, Ingraham JL, Lin ECC, Low KB, Magasanik B, et al., editors. Escherichia coli and Salmonella: Celular and Molecular Biology. Washington, DC: American Society of Microbiology; 1996. p. 123–57.Google Scholar
- Lindsey RL, Fedorka-Cray PJ, Frye JG, Meinersmann RJ. Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates. Appl Environ Microbiol. 2009;75(7):1908–15.PubMed CentralView ArticlePubMedGoogle Scholar
- Ogbolu DO, Daini OA, Ogunledun A, Terry Alli OA, Webber MA. Dissemination of IncF plasmids carrying beta-lactamase genes in Gram-negative bacteria from Nigerian hospitals. J Infect Dev Ctries. 2013;7(5):382–90. doi:10.3855/jidc.2613.View ArticlePubMedGoogle Scholar
- Doumith M, Dhanji H, Ellington MJ, Hawkey P, Woodford N. Characterization of plasmids encoding extended-spectrum beta-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. J Antimicrob Chemother. 2012;67(4):878–85. doi:10.1093/jac/dkr553.View ArticlePubMedGoogle Scholar
- Mata C, Miro E, Alvarado A, Garcillan-Barcia MP, Toleman M, Walsh TR, et al. Plasmid typing and genetic context of AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007. J Antimicrob Chemother. 2012;67(1):115–22. doi:10.1093/jac/dkr412.View ArticlePubMedGoogle Scholar
- Karczmarczyk M, Wang J, Leonard N, Fanning S. Complete nucleotide sequence of a conjugative IncF plasmid from an Escherichia coli isolate of equine origin containing bla CMY-2 within a novel genetic context. FEMS Microbiol Lett. 2014;352(1):123–7. doi:10.1111/1574-6968.12364.View ArticlePubMedGoogle Scholar
- Kapperud G, Gustavsen S, Hellesnes I, Hansen AH, Lassen J, Hirn J, et al. Outbreak of Salmonella typhimurium infection traced to contaminated chocolate and caused by a strain lacking the 60-megadalton virulence plasmid. J Clin Microbiol. 1990;28(12):2597–601.PubMed CentralPubMedGoogle Scholar
- Olsen JE, Brown DJ, Thomsen LE, Platt DJ, Chadfield MS. Differences in the carriage and the ability to utilize the serotype associated virulence plasmid in strains of Salmonella enterica serotype Typhimurium investigated by use of a self-transferable virulence plasmid, pOG669. Microb Pathog. 2004;36(6):337–47.View ArticlePubMedGoogle Scholar
- Garcia-Quintanilla M, Casadesus J. Virulence plasmid interchange between strains ATCC 14028, LT2, and SL1344 of Salmonella enterica serovar Typhimurium. Plasmid. 2011;65(2):169–75. doi:10.1016/j.plasmid.2010.12.001.View ArticlePubMedGoogle Scholar
- Heithoff DM, Shimp WR, Lau PW, Badie G, Enioutina EY, Daynes RA, et al. Human Salmonella clinical isolates distinct from those of animal origin. Appl Environ Microbiol. 2008;74(6):1757–66.PubMed CentralView ArticlePubMedGoogle Scholar
- Fierer J, Guiney DG. Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J Clin Invest. 2001;107(7):775–80.PubMed CentralView ArticlePubMedGoogle Scholar
- Jones GW, Rabert DK, Svinarich DM, Whitfield HJ. Association of adhesive, invasive, and virulent phenotypes of Salmonella typhimurium with autonomous 60-megadalton plasmids. Infect Immun. 1982;38(2):476–86.PubMed CentralPubMedGoogle Scholar
- Gulig PA, Curtiss 3rd R. Plasmid-associated virulence of Salmonella typhimurium. Infect Immun. 1987;55(12):2891–901.PubMed CentralPubMedGoogle Scholar
- Ibarra JA, Knodler LA, Sturdevant DE, Virtaneva K, Carmody AB, Fischer ER, et al. Induction of Salmonella pathogenicity island 1 under different growth conditions can affect Salmonella-host cell interactions in vitro. Microbiology. 2010;156(Pt 4):1120–33. doi:10.1099/mic.0.032896-0.PubMed CentralView ArticlePubMedGoogle Scholar
- Ramachandran G, Perkins DJ, Schmidlein PJ, Tulapurkar ME, Tennant SM. Invasive Salmonella Typhimurium ST313 with Naturally Attenuated Flagellin Elicits Reduced Inflammation and Replicates within Macrophages. PLoS Negl Trop Dis. 2015;9(1), e3394. doi:10.1371/journal.pntd.0003394.PubMed CentralView ArticlePubMedGoogle Scholar
- Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489–99. doi:10.1016/S0140-6736(11)61752-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis. 2002;8(5):490–5.PubMed CentralView ArticlePubMedGoogle Scholar
- Hopkins KL, Kirchner M, Guerra B, Granier SA, Lucarelli C, Porrero MC, et al. Multiresistant Salmonella enterica serovar 4,,12:i:- in Europe: a new pandemic strain? Euro Surveill. 2010;15(22):19580.PubMedGoogle Scholar
- Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, Gordon MA, et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 2009;19(12):2279–87. doi:10.1101/gr.091017.109.PubMed CentralView ArticlePubMedGoogle Scholar
- Threlfall J, Ward L, Rowe B. Multiresistant Salmonella Typhimurium DT 104 and salmonella bacteraemia. Lancet. 1998;352:287–8.View ArticlePubMedGoogle Scholar
- Silva C, Calva E, Calva JJ, Wiesner M, Fernandez-Mora M, Puente JL et al. Complete genome sequence of a human-invasive Salmonella Typhimurium strain of the emerging sequence type 213 harboring a multidrug resistance IncA/C plasmid and a blaCMY-2-carrying IncF plasmid. Genome Announc. In pressGoogle Scholar
- Calva E, Silva C, Zaidi MB, Sanchez-Flores A, Estrada K, Silva GG, et al. Complete Genome Sequencing of a Multidrug-Resistant and Human-Invasive Salmonella enterica Serovar Typhimurium Strain of the Emerging Sequence Type 213 Genotype. Genome Announc. 2015;3(3). doi:10.1128/genomeA.00663-15.
- Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–33. doi:10.1128/MMBR.00016-10.PubMed CentralView ArticlePubMedGoogle Scholar
- Liebana E, Carattoli A, Coque TM, Hasman H, Magiorakos AP, Mevius D, et al. Public health risks of enterobacterial isolates producing extended-spectrum beta-lactamases or AmpC beta-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. Clin Infect Dis. 2013;56(7):1030–7. doi:10.1093/cid/cis1043.View ArticlePubMedGoogle Scholar
- Silva C, Calva E, Maloy S. One Health and Food-Borne Disease: Salmonella: Transmission between Humans, Animals and Plants. Microbiol Spectrum. 2014;2:OH-0020-2013. doi:10.1128/microbiolspec.OH-0020-2013.Google Scholar
- Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981;291(5812):238–9.View ArticlePubMedGoogle Scholar
- Bustamante VH, Martínez LC, Santana FJ, Knodler LA, Steele-Mortimer O, Puente JL. HilD-mediated transcriptional cross-talk between SPI-1 and SPI-2. Proc Natl Acad Sci U S A. 2008;105(38):14591–6. doi:10.1073/pnas.0801205105.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee AK, Detweiler CS, Falkow S. OmpR regulates the two-component system SsrA-ssrB in Salmonella pathogenicity island 2. J Bacteriol. 2000;182(3):771–81.PubMed CentralView ArticlePubMedGoogle Scholar
- Bijlsma JJ, Groisman EA. The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica. Mol Microbiol. 2005;57(1):85–96. doi:10.1111/j.1365-2958.2005.04668.x.View ArticlePubMedGoogle Scholar